Lab quality diabetes testing, at home.

Home testing services for the detection of diabetes.

Digostics' revolutionary new testing platforms offer the world's first and only alternative to in-clinic testing for glucose intolerance by enabling the oral glucose tolerance test (OGTT) to be performed at home. 

Digostics' breakthrough solution, GTT@home, provides clinic-equivalent test results with applications in gestational diabetes, type one diabetes, prediabetes, cystic fibrosis and clinical trials.

Simplified testing.  Increased patient throughput.  Better outcomes. 

Home Testing for Early Diabetes Detection

Digostics' home testing platforms ensure more patients can be easily tested, on time.

By removing the need for in-clinic tests, we provide a gateway to more extensive testing, faster results and unparalleled opportunities for earlier clinical intervention.

• 100% focus on diabetes
• Cutting-edge testing platforms
• Pioneers of accurate home testing
• Introduced the world's first home OGTT
• Leaders in patient-centred design
• Open architecture and system interoperability.